List of Excipients in API NABUMETONE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing NABUMETONE
Detailed excipient profiles for NABUMETONE
Excipient focus: AMMONIUM LAURETH-5 SULFATE
NABUMETONE drug variants containing AMMONIUM LAURETH-5 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nabumetone | 0615-7645 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing AMMONIUM LAURETH-5 SULFATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
NABUMETONE drug variants containing CELLULOSE, MICROCRYSTALLINE
NABUMETONE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
NABUMETONE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nabumetone | 0615-7645 |
| Blenheim Pharmacal Inc | nabumetone | 10544-120 |
| Blenheim Pharmacal Inc | nabumetone | 10544-273 |
| Altura Pharmaceuticals Inc | nabumetone | 63874-607 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
NABUMETONE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Carwin Pharmaceutical Associates LLC | nabumetone | 15370-170 |
| St Mary's Medical Park Pharmacy | nabumetone | 60760-185 |
| Chartwell RX LLC | nabumetone | 62135-145 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
NABUMETONE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nabumetone | 0615-7645 |
| Blenheim Pharmacal Inc | nabumetone | 10544-273 |
| STAT RX USA LLC | nabumetone | 16590-160 |
| Par Pharmaceutical Inc | nabumetone | 49884-649 |
| Altura Pharmaceuticals Inc | nabumetone | 63874-607 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C YELLOW NO. 6
NABUMETONE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | nabumetone | 16590-160 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
NABUMETONE drug variants containing FERRIC OXIDE RED
NABUMETONE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
NABUMETONE drug variants containing FERRIC OXIDE YELLOW
NABUMETONE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
NABUMETONE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nabumetone | 0615-7667 |
| PD-Rx Pharmaceuticals Inc | nabumetone | 43063-859 |
| medsource pharmaceuticals | nabumetone | 45865-997 |
| Quality Care Products LLC | nabumetone | 55700-765 |
| Preferred Pharmaceuticals Inc | nabumetone | 68788-7532 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
NABUMETONE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Nexgen Pharma Inc | nabumetone | 0722-7076 |
| Carwin Pharmaceutical Associates LLC | nabumetone | 15370-170 |
| BLUCREST PHARMACEUTICALS LLC | nabumetone | 73684-101 |
| LGM PHARMA SOLUTIONS LLC | nabumetone | 79739-7076 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
NABUMETONE drug variants containing HYPROMELLOSE
NABUMETONE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
NABUMETONE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nabumetone | 0615-7645 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
NABUMETONE drug variants containing HYPROMELLOSE 2910
NABUMETONE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
NABUMETONE drug variants containing HYPROMELLOSES
NABUMETONE drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
NABUMETONE drug variants containing MAGNESIUM STEARATE
NABUMETONE drug variants not containing MAGNESIUM STEARATE
Excipient focus: POLYETHYLENE GLYCOL
NABUMETONE drug variants containing POLYETHYLENE GLYCOL
NABUMETONE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 200
NABUMETONE drug variants containing POLYETHYLENE GLYCOL 200
NABUMETONE drug variants not containing POLYETHYLENE GLYCOL 200
Excipient focus: POLYETHYLENE GLYCOL 400
NABUMETONE drug variants containing POLYETHYLENE GLYCOL 400
NABUMETONE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
NABUMETONE drug variants containing POLYETHYLENE GLYCOL 6000
NABUMETONE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOLS
NABUMETONE drug variants containing POLYETHYLENE GLYCOLS
NABUMETONE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
NABUMETONE drug variants containing POLYSORBATE 80
NABUMETONE drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
NABUMETONE drug variants containing POVIDONE
NABUMETONE drug variants not containing POVIDONE
Excipient focus: POVIDONES
NABUMETONE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | nabumetone | 33261-077 |
| >Company | >Ingredient | >NDC |
NABUMETONE drug variants not containing POVIDONES
Excipient focus: SILICON DIOXIDE
NABUMETONE drug variants containing SILICON DIOXIDE
NABUMETONE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
NABUMETONE drug variants containing SODIUM LAURYL SULFATE
NABUMETONE drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Nexgen Pharma Inc | nabumetone | 0722-7076 |
| BLUCREST PHARMACEUTICALS LLC | nabumetone | 73684-101 |
| LGM PHARMA SOLUTIONS LLC | nabumetone | 79739-7076 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
NABUMETONE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
NABUMETONE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
NABUMETONE drug variants containing STARCH, CORN
NABUMETONE drug variants not containing STARCH, CORN
Excipient focus: TALC
NABUMETONE drug variants containing TALC
NABUMETONE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
NABUMETONE drug variants containing TITANIUM DIOXIDE
NABUMETONE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
NABUMETONE drug variants containing TRIACETIN
NABUMETONE drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
